FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

4038211000001106: Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
134151000001110 Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
134161000001113 Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
17800901000001119 Metopirone 250mg capsules (Alliance Pharmaceuticals Ltd) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17801001000001111 Metopirone 250mg capsules (Alliance Pharmaceuticals Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
69334301000001116 Metopirone 250mg capsules (HRA Pharma UK Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Is a Product containing precisely metyrapone 250 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has active ingredient Metyrapone false Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Is a Metopirone true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has specific active ingredient Metyrapone true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) 100 capsule Is pack of False Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) 100 capsule Has AMP True Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start